This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Novartis Ag, Statens Institutt for Folkehelse. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,978 
1 out of 2 Years Active: 2011
Title: Bjorn Haneberg: Innovator in Combination Vaccines
Introduction
Bjorn Haneberg is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of immunology, particularly in the development of combination vaccines. His work focuses on innovative solutions for treating and preventing infections.
Latest Patents
Haneberg holds 1 patent that describes combination vaccines for treating or preventing infections. The patent details the inclusion of serogroup B proteoliposomic vesicles and serogroup C conjugated oligosaccharides, showcasing his commitment to advancing vaccine technology.
Career Highlights
Throughout his career, Haneberg has worked with prominent organizations such as Novartis AG and the Norwegian Institute of Public Health. His experience in these institutions has allowed him to contribute to significant advancements in public health and vaccine development.
Collaborations
Haneberg has collaborated with esteemed colleagues, including Dan M Granoff and Howard V Raff. These partnerships have further enriched his research and innovation in the field of vaccines.
Conclusion
Bjorn Haneberg's work in combination vaccines exemplifies his dedication to improving public health through innovative solutions. His contributions are vital in the ongoing fight against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile